Does Moringa Supplementation Blood Pressure Randomized Trial work?

Updated August 2026

Quick Answer

Moringa Supplementation Blood Pressure Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Moringa oleifera is suggested as an antihypertensive and anti-obesity agent, but there is insufficient evidence to establish a causal link between Moringa oleifera and reductions in blood pressure and body measurements in humans.

Key Takeaways

  • 01Moringa oleifera is suggested as an antihypertensive and anti-obesity agent, but there is insufficient evidence to establish a causal link between Moringa oleifera and reductions in blood pressure and body measurements in humans. [Samarin MM (2026)]
  • 02The results indicated that Moringa oleifera consumption significantly reduced systolic blood pressure (SBP) by weighted mean differences (WMDs): -6.00 mmHg, p p p = 0.435) and body weight ( p = 0.938) compared to those who did not consume Moringa oleifera . [Samarin MM (2026)]
  • 03This systematic review and meta-analysis seek to examine the effects of Moringa oleifera on body weight and blood pressure. [Samarin MM (2026)]
  • 04A substantial portion of this global burden is attributable to modifiable metabolic risk factors, including increased fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TAGs) [,,]. [Crișan Diana (2025)]
The current Migaku evidence database contains 2 reusable source documents for Moringa Supplementation Blood Pressure Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Moringa oleifera is suggested as an antihypertensive and anti-obesity agent, but there is insufficient evidence to establish a causal link between Moringa oleifera and reductions in blood pressure and body measurements in humans. [Samarin MM (2026); evidence level 1] - The results indicated that Moringa oleifera consumption significantly reduced systolic blood pressure (SBP) by weighted mean differences (WMDs): -6.00 mmHg, p p p = 0.435) and body weight ( p = 0.938) compared to those who did not consume Moringa oleifera . [Samarin MM (2026); evidence level 1] - This systematic review and meta-analysis seek to examine the effects of Moringa oleifera on body weight and blood pressure. [Samarin MM (2026); evidence level 1] - A substantial portion of this global burden is attributable to modifiable metabolic risk factors, including increased fasting blood glucose (FBG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TAGs) [,,]. [Crișan Diana (2025); evidence level 1] - These metabolic risk factors are frequently accompanied by anthropometric changes (i.e., increased body weight [BW], body mass index [BMI], waist circumference [WC], and excess adiposity) and elevated blood pressure (systolic and diastolic) [,,]. [Crișan Diana (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The Effect of <i>Moringa oleifera</i> on Body Weight and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  2. Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment